Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer

With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Benlin HUANG, Yong DUAN
Médium: Artigo
Jazyk:Chinês
Vydáno: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Edice:Chinese Journal of Lung Cancer
Témata:
Immune checkpoint inhibitors
Small cell lung cancer
PD-1
PD-L1
CTLA-4
On-line přístup:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky